Topics
October 2020 | Meeting Minute
Subretinal Gene Therapy
This new technology is filled with promise.
Christina Y. Weng, MD, MBA, and Jonathan F. Russell, MD, PhD
Intraocular Tumors: A Look Into the Future
The Taylor Smith and Victor Curtin Lecture was given by Carol L. Shields, MD, at this year’s meeting.
Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD
Aspen Retinal Detachment Society Meeting Coverage: Ocular Oncology and Retinal Gene Therapy
Timothy G. Murray, MD, MBA
November 3, 2026
Moorfields Eye Hospital Appoints Aruna Mehta as New Chair
Harrow Launches HarrowRx Prescribing Platform to Streamline Ophthalmic Medication Access
November 2, 2026
FDA Approves Lucamzi as Ranibizumab Biosimilar for Retinal Diseases
OpZira Completes Stage II Audit for AdaptDx Pro, Advances Plans for European CE Marking
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar